TNF-induced mitochondrial changes and activation of apoptotic proteases are inhibited by A20

Free Radical Biology and Medicine

Volumn 25, Issue 1, 1998, Pages 57-65

  Wissing, Dorte ^a   Mouritzen, Helle ^a   Jäättelä, Marja ^a  

^a Institute of Biology   (Denmark)

Author keywords

Apoptosis; Caspases; Free radicals; Mitochondrial membrane potential; Tumor necrosis factor

Indexed keywords

FREE RADICAL; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASES; DOXORUBICIN; ENDOPEPTIDASES; ENZYME ACTIVATION; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MITOCHONDRIA; NUCLEAR PROTEINS; PROTEASE INHIBITORS; PROTEIN BIOSYNTHESIS; PROTEINS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; ZINC FINGERS;

POX VIRUS;

EID: 0032124879     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00043-4     Document Type: Article

References (39)

1. Dixit V. M., Green S., Sarma V., Prochownik E. V. Tumor necrosis factor-α induction of novel genes in human endothelial cells including a macrophage specific chemotaxin. J. Biol. Chem. 265:1990;2973-2978.
2. Opipari A. W., Boguski M. S., Dixit V. M. The A20 cDNA induced by tumor necrosis factor-α encodes a novel type of zinc finger protein. J. Biol. Chem. 265:1990;14705-14708.
3. Sarma V., Lin Z., Clark L., Rust B. M., Tewari M., Noelle R. J., Dixit V. M. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:1995;12343-12346.
4. Tewari M., Wolf F. W., Seldin M. F., O'Shea K. S., Dixit V. M., Turka L. A. Lymphoid expression and regulation of A20, an inhibitor of programmed cell death. J. Immunol. 154:1995;1699-1706.
5. Opipari A. W., Hu H. M., Yabkowitz R., Dixit V. M. The A20 zinc-finger protein protects cells from TNF cytotoxicity. J. Biol. Chem. 267:1992;12424-12427.
6. Jäättelä M., Mourizen H., Elling F., Bastholm L. A20 zinc finger protein inhibits TNF and IL-1 signaling. J. Immunol. 156:1996;1166-1173.
7. Yamauchi N., Kuriyama H., Watanabe N., Neda H., Maeda M., Niitsu Y. Intracellular hydroxyl radical production induced by recombinant tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res. 49:1989;1671-1675.
8. Schreck R., Rieber P., Bauerle P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
9. Freeman B. A., Crapo J. D. Biology of disease. Free radicals and tissue injury. Lab. Invest. 47:1982;412-425.
10. Kroemer G., Petit P., Zamzami N., Vayssière J.-L., Mignotte B. The biochemistry of programmed cell death. FASEB J. 9:1995;1277-1287.
11. Zimmerman R. J., Marafino B. J. J., Chan A., Landre P., Winkelhake J. L. The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. J. Immunol. 142:1989;1405-1409.
12. Wong G. H. W., Goeddel D. V. Induction of manganous superoxide dismutase by tumor necrosis factor Possible protective mechanism . Science. 242:1988;941-944.
13. Wong G. H. W., Elwell J. H., Oberley L. W., Goeddel D. V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58:1989;923-931.
14. Goossens V., Grooten J., De Vos K., Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA. 92:1995;8115-8119.
15. Schulze-Osthoff K., Bakker A. C., Vanhaesebroeck B., Beyaert R., Jacob W. A., Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267:1992;5317-5323.
16. Schulze-Osthoff K., Krammer P. H., Dröge W. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13:1994;4587-4596.
17. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirch T., Susin S. A., Petit P. X., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:1995;367-377.
18. Shimizu S., Eguchi Y., Kamiike W., Waguri S., Uchiyama Y., Matsuda H., Tsujimoto Y. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene. 13:1996;21-29.
19. De Valck D., Heyninck K., Van Criekinge W., Contreras R., Beyaert R., Fiers W. A20, an inhibitor of cell death, self-associates by its zinc finger domain. FEBS Lett. 384:1996;61-64.
20. Vincenz C., Dixit V. M. 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J. Biol. Chem. 271:1996;20029-20034.
21. Song H. Y., Rothe M., Goeddel D. V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl. Acad. Sci. USA. 93:1996;6721-6725.
22. Jäättelä M., Pinola M., Saksela E. Heat shock inhibits the cytotoxic action of TNF in tumor cells but does not alter its noncytotoxic actions in adrenal and endothelial cells. Lymphokine Cytokine Res. 10:1991;119-125.
23. 2 in breast carcinoma cells. Oncogene. 10:1995;2297-2305.
24. Wissing D., Mouritzen H., Egeblad M., Poirier G. G., Jäättelä M. Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;5073-5077.
25. Trauth B. C., Klas C., Peters A. M. J., Matzku S., Möller P., Falk W., Debatin K.-M., Krammer P. H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 245:1989;301-305.
26. Jäättelä M., Saksela K., Saksela E. Heat shock protects WEHI-164 target cells from the cytolysis by tumor necrosis factors α and β Eur. J. Immunol. 19:1989;1413-1417.
27. Ubezio P., Civoli F. Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells. Free Radic. Biol. Med. 16:1994;509-516.
28. Karlseder J., Wissing D., Holzer G., Orel L., Sliutz G., Auer H., Jäättelä M., Simon M. M. Hsp70 overexpression mediates the escape of a doxorubicin induced G2 cell cycle arrest. Biochem. Biophys. Res. Commun. 220:1996;153-159.
29. Johnson L. V., Walsh M. L., Bockus B. J., Chen L. B. Monitoring of relative mitochondrial transmembrane potential in living cells by fluorescence microscopy. J. Cell Biol. 88:1981;526-535.
30. Kauffmann S. H., Desnoyers S., Ottaviano Y., Davidson N. E., Poirier G. G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase An early marker of chemotherapy-induced apoptosis . Cancer Res. 53:1993;3976-3985.
31. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
32. Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D. R., Poirier G. G., Salvesen G. S., Dixit V. M. Yama/CPP32β, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81:1995;801-809.
33. Bray T. M., Bettger W. J. The physiological role of zinc as antioxidant. Free Radic. Biol. Med. 8:1990;281-291.
34. Schreck R., Meier B., Männel D. N., Dröge W., Bauerle P. A. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1992;1181-1194.
35. Hsu H., Xiong J., Goeddel D. V. The TNF receptor 1-associated protein TRADD signals death and NF-κB activation. Cell. 81:1995;495-504.
36. Hsu H., Shu H.-B., Pan M.-G., Goeddel D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:1996;299-308.
37. Natoli G., Costanzo A., Ianni A., Templeton D. J., Woodgett J. R., Balsano C., Levrero M. Activation of SAPK/JNK by TNF receptor through a noncytotoxic TRAF2-dependent pathway. Science. 275:1997;200-203.
38. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T.-I., Jones D. P., Wang X. Prevention of apoptosis by Bcl-2 release of cytochrome c from mitochondria blocked . Science. 275:1997;1129-1132.
39. Susin S. A., Zamzami N., Castedo M., Hirch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1996;1331-1341.